Skip Ribbon Commands
Skip to main content

Learning Resources

Givensight

Givensight Issue 4: Fall 2013

Givensight_Issue_3_Cover.jpg

This new edition features Dr. Anish Sheth discussing the Bravo® pH monitoring system and Digitrapper® pH-Z monitoring system in the evaluation of patients with suspected GERD. Dr. Sheth is the former director of the gastrointestinal motility program at Yale University School of Medicine. Dr. Sheth completed his GI training at Yale, and while there, worked to establish a motility referral center specializing in both upper and lower gastrointestinal disorders. He has recently established an esophageal center of excellence at the University Medical Center of Princeton featuring a comprehensive range of diagnostic and therapeutic services, including high resolution esophageal manometry, impedance and capsule-based pH monitoring, and radiofrequency ablation for Barrett's esophagus. This edition of Givensight features Dr. Sheth discussing GERD and the diagnostic approach to GERD, particularly in patients with symptoms refractory to PPI therapy. The article explains the rationale for use of these tools, as well as how to deploy them and interpret the results of the studies. This discussion is followed by case studies that demonstrate the principles involved in evaluation of patients in this setting. 



Givensight Issue 3: Fall 2012

Givensight_Issue_3_Cover.jpg
 

 

This new edition features two articles addressing the collaboration between a community physician (Dr. Russell Havranek) and a community radiologist (Dr. Ariel Kruger) in the management of Crohn’s patients. Dr. Russell Havranek received his medical degree from the University of Nebraska and then completed an internal medicine residency, gastroenterology fellowship and advanced fellowship in the liver transplant program at the University of Texas Health Science Center in San Antonio, where he is currently an Assistant Professor of Medicine. Dr Havranek is also the President and CEO of his private practice, Gastroenterology Clinic of San Antonio. Dr. Havranek has authored a general review of the importance of monitoring Crohn’s disease, including a case study approach to management and monitoring Crohn’s patients.

 

 

 

 

Givensight Issue 2: Spring 2012

Givensight_Issue_2_Cover.jpg

This new edition features two articles addressing the clinical usefulness of our HR manometry systems; “Esophageal Manometry: The Case For High Resolution Over Conventional Evaluations” and “High Resolution Anorectal Manometry: Diagnosing Dyssynergic Defecation and Fecal Incontinence.” Dr. Anish Sheth, former director of the gastrointestinal motility program at Yale University School of Medicine and author of both of these papers.  Dr. Sheth completed his GI training at Yale, and while there, worked to establish a motility referral center specializing in both upper and lower gastrointestinal disorders.  He has recently established an esophageal center of excellence at the University Medical Center of Princeton featuring a comprehensive range of diagnostic and therapeutic services, including high - resolution esophageal manometry, impedance and wireless pH monitoring, and radiofrequency ablation for Barrett's esophagus. 

 

 

 

Givensight Issue 1: Fall 2011

GivenSight_Issue1_Cover_Page_sm.jpg

 

 

This inaugural edition features two articles, “The Expanding Role of PillCam SB Capsule Endoscopy in Crohn’s Disease,” and “Best Practices for Diagnosing Iron Deficiency Anemia and Obscure GI Bleeding.” The authors are, respectively Dr. Blair Lewis, Clinical Professor of Medicine, Gastroenterology at Mt. Sinai Hospital, New York and Professor Ian Gralnek, Head of the GI Outcomes Unit and Senior Physician, Department of Gastroenterology, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology. Both are prominent capsule endoscopy researchers among their many interests, and well known for their pioneering and educational efforts in this field. The articles are literature-based reviews of the most up-to-date approaches in these indications, and include patient vignettes and FAQ’s. In this regard, they reflect our recent FDA clearance for PillCam SB use in these indications.

 

 



​ ​​​